From the National Center for Advancing Translational Sciences
From the National Institutes of Health
Clinicopathologic Overlap Between Rare Eosinophilic Disorders: Implications for Clinical Trial Design
Wednesday, July 17, 2013
The short-term goals of the workshop are: 1) to bring together a multidisciplinary group of clinician-scientists with expertise in rare eosinophilic disorders to discuss issues related to improved clinical trial design, including the utility of current diagnostic criteria and the validation of biomarkers of disease activity, 2) to continue fostering collaborative relationships between multidisciplinary clinical and basic science researchers interested in eosinophilic disorders, and 3) to provide a venue for establishing a formal multidisciplinary clinical subgroup of the IES. It is anticipated that the findings from this workshop will lead to improved design of multicenter clinical trials to assess the safety and efficacy of novel agents for the treatment of these disorders. Furthermore, establishing a formal clinical subgroup of IES will facilitate advocacy for new clinical trials for rare eosinophilic disorders.
Contact: Dr. Amy Klion (301) 435-8903
National Institute of Allergy and Infectious Diseases
Office of Rare Diseases Research